drugset / Trial / NCT00313131
Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments
Phase 3
Completed
1524 enrolled
University of Sherbrooke
Canadian International Development Agency · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole for 7 days, plus vaginal clotrimazole for 3 days) in the syndromic management of women presenting with vaginal discharge in primary health care centers of Ghana, Togo, Guinea and Mali. It was designed as an effectiveness trial, i.e. it was done under conditions typical of routine work in these health centers
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clotrimazole | Unknown | — | Other |
| Subject | Fluconazole | Small molecule | — | — |
| Subject | Metronidazole | Small molecule | — | — |
| Subject | tinidazole | Small molecule | — | — |